A forum for researchers, students and applicants in the field of cyclodextrin technology
SARS-CoV-2 replication in cell cultures has been shown to be inhibited by ivermectin. However, ivermectin’s low aqueous solubility and bioavailability hinders
On July 27, the Cyclo Therapeutics, a clinical stage biotechnology firm dedicated to developing life-changing medicines through science and innovation
The effect of CD on the amorphous drug solubility and the maximum thermodynamic activity of the drug in the aqueous
The purpose of enzyme therapies (ERT) is simple: patients who suffer from enzyme deficiency should be treated by administering enzymes
Molecular dynamic (MD) simulations have been performed to investigate the inclusion behavior of anthracene (ANT) into three kinds of CDs,
Mallinckrodt Pharmaceuticals has reached an agreement to divest and transfer the Investigational New Drug (IND) application for experimental drug adrabetadex
Pharmaceutical Technology has published an evaluation from experts on vaccine development. According to recent market research, the vaccines market is
A recent review of Jicsinszky et al. (2021) gave an overview on cyclodextrins’ benefits and limitations in various antiviral drug
Protein-based pharmaceutical products are subject to a variety of environmental stressors, during both production and shelf-life. In order to preserve
Gram-negative bacteria possess numerous defenses against antibiotics, due to the intrinsic permeability barrier of their outer membrane, explaining the recalcitrance
